Prospective randomized controlled trial of oral sodium phosphate and polyethylene glycol lavage in bowel preparation for colonoscopy - VisiN study

Department of Gastroenterology, The University of Tokyo Hospital0 个研究点目标入组 200 人开始时间: 2008年8月7日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•The following proceduresis excluded from the criteria 1) Patients with uncontrolled congestive heart failure, unstable angina, untreated cardiac arrhythmia, prolong QT interval, myocardial infarction, percutaneous transluminal coronary angioplasty or previous coronary artery bypass graft surgery, basic heart disease (valvular disease, cardiomyopathy, and arrhythmia, etc.) 2) Patients with the presence of ascites 3) Patients with acute bowel obstruction or pseudo-obstruction of the bowel 4) Patients with toxic megacolon 5) Patients with biopsy-proven acute phosphate nephropathy 6) Patients who is known allergy or hypersensitivity to NaP salts or PEG 7) Patients with renal insufficiency (creatinine>2.0mg/dL or BUN>25mg/dL) 8) Patients with a history of convulsive attack or Patients at higher risk of convulsive attack 9) Patients with severe chronic constipation 10) Patients with clinical symptoms caused by narrowing of colon lumen or diverticulosis of colon 11) Patients who need emergency colonoscopy 12) Patients with inflammatory bowel disease 13) Pregnant females and lactating women 14) Patients who needs endoscopic therapy (EMR, polypectomy, etc.) 15) Patients who have past history of abdominal surgery other than appendectomy 16) Patients whom examination the responsible(contributory) doctor evaluate inappropriate as study subjects

发起方

Department of Gastroenterology, The University of Tokyo Hospital